All the synthesised thiazolyl-pyrazolines have been screened for their inhibitory activities against EGFR and VEGFR-2 kinases and for their cytotoxic effect against nine cell lines derived from five tumour subpanels. The gene discussed is KDR; the disease is neoplasm.